@kaiko_bosnaa4: A cancer pill that costs $900 in the U.S. is sold for under $1 in India. The cost of the blood cancer dru-g Revlimid has spotlighted a massive healthcare divide and ignited global anger over medical price gouging. A single pill of the medication costs approximately $900 in the United States. However, the same life-saving capsule is priced between 30 cents and $3.00 on Indian markets. The dramatic contrast has led one U.S. influencer, who posts under the Instagram handle Spicy , to declare that American patients are "being robbed.” The video drew millions of views and igniting intense discussions about why essential medications remain so financially out of reach in Western countries. Experts point to India's robust generic pharmaceutical industry and government-subsidized healthcare as the cause for the price disparity. Meanwhile, in the U.S., stringent patent protections and a lack of direct price controls keep proprietary dru-g costs extraordinarily high. As patients increasingly seek personal imports of generic alternatives to manage chronic illnesses, experts say the pressure is mounting on Western lawmakers to address the unsustainable financial burden of essential healthcare. source: India Today Trending Desk (2026). Woman shocked by India-US price gap for life-saving cancer medicine, shares video. India Today. #cancer #cancertreatment #healt #medicina #healthcare

Iranian_Missile

Open In TikTok:

Region: TR

Tuesday 21 July 2026 01:09:01 GMT